As generic versions of AstraZeneca’s blockbuster drug ticagrelor prepare to enter the market, The BMJ raises fresh concerns over the integrity of the clinical trials that underpinned its approval.

Fourteen years after AstraZeneca’s blood thinner Brilinta reached the market and now faces generic competition, the data that ...

The twice-daily pill is given to people with acute coronary syndrome -a sudden reduction of blood to the heart-reducing the ...

MEDICS have raised concerns over a drug taken by millions to prevent heart attacks and strokes, claiming key safety data was “misreported” by its manufacturer AstraZeneca.

Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic ...

St. Clare Health Mission's innovative mobile healthcare program receives national recognition for expanding healthcare access for underserved populations.

Table V. Bleeding time and platelet aggregation in volunteers treated with placebo, meloxicam or indomethacin. [ 74 ] Values are expressed as means ± SE Treatment ...

1.1 This Site is owned and operated by The Associated Press and/or its affiliates (collectively, “AP”). All of the content elements displayed and/or downloadable on this Site, including photographic ...

Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.